APA (7th ed.) Citation

Simon, S. C. S., Müller, V., & Utikal, J. (2023). Case report: Therapeutic potential of T-VEC in combination with MEK inhibitors in melanoma patients with NRAS mutation. Frontiers in oncology, 13, . https://doi.org/10.3389/fonc.2023.1111119

Chicago Style (17th ed.) Citation

Simon, Sonja C. S., Verena Müller, and Jochen Utikal. "Case Report: Therapeutic Potential of T-VEC in Combination with MEK Inhibitors in Melanoma Patients with NRAS Mutation." Frontiers in Oncology 13 (2023). https://doi.org/10.3389/fonc.2023.1111119.

MLA (9th ed.) Citation

Simon, Sonja C. S., et al. "Case Report: Therapeutic Potential of T-VEC in Combination with MEK Inhibitors in Melanoma Patients with NRAS Mutation." Frontiers in Oncology, vol. 13, 2023, https://doi.org/10.3389/fonc.2023.1111119.